| Ref ID | 791 |
| First Author | R.L. Pacheco |
| Journal | RESEARCH SYNTHESIS METHODS |
| Year Of Publishing | 2022 |
| URL | https://onlinelibrary.wiley.com/doi/abs/10.1002/jrsm.1507?casa_token=yYdbdaAW1tQAAAAA:uStCivZDWHJbDfny6ZOfuk1bch5EqDZYM8cEqMhkYO2BCwJbOxUNPwcLAvpjAN8vgzZ05K0CDBE35dWs |
| Keywords |
• Disclosure • Allegiance • Author • Cochrane |
| Problem(s) |
• Conflict of interest statement or disclosures for review authors missing • Non-financial conflicts of interest of review authors • Weaknesses identified in some Cochrane reviews |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | Brazil |
| Aim | To assess adherence to Cochrane's editorial conflict of interest policy in 260 published Cochrane reviews in issues 1 to 6 from 2019 of the Cochrane Database of Systematic Reviews. |
| Level of Investigation | Descriptive |
| Summary of Findings | From 260 published Cochrane reviews in issues 1 to 6 from 2019 of the Cochrane Database of Systematic Reviews. 133 (51.2%, 133/260) of Cochrane reviews had at least one author that was also listed as an editor in the Cochrane Review Group. Of these, only five (3.8%, 5/133) appropriately declared the conflict according to Cochrane policy. In 6.5% (17/133) Cochrane Reviews, the contact author had a leading editorial position within the Cochrane Review Group and in only four of 17 was this declared according to Cochrane policy. No Cochrane review with the contact author who also had a leading editorial position described methods to prevent any potential issues related to this scenario during the editorial process in accordance with Cochrane policy. |
| Number of systematic reviews included | 260 |
| Number of eligible systematic reviews assessed | 260 |
| Treatment impacted | No |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |